| Tag | Content |
|---|
EnhancerAtlas ID | HS060-12445 | Organism | Homo sapiens | Tissue/cell | GM12891 | Coordinate | chr16:12087800-12089080 | | | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_11163 | chr16:12085712-12094005 | CD20 |
| | | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
| | | Number: 1 | ID | Chromosome | Start | End |
| GH16I011993 | chr16 | 12087459 | 12089656 |
| Enhancer Sequence | AATCCCGTCT CTACTAAAAA TACAAAAATT AGCTGGGCAT GGTAGCAGGA GCCTGTAATC 60
TCAGCTACTT GGGAGGCTGA GGCAGGATAA TCGCTTGAAC CCAGGAGGCA GAGGTTGCAG 120
TGAGCTGAGA TCGCGCCATT GCACTCCAGC CTGGGTGACA AGAGCAAGAC TCCGTCTACA 180
AACAAACAAC AACAACAAAA CATTAAAGAG AGACCCAACT AGGTGACTGA CTTTCCCGTG 240
CACATGAGGA TTCTGAGTAG AGTTAGGGAG TGTCAGCTGA CTGCATTTCT CAGACAGGTT 300
TGTGGACCCC TGGAGGTATT CCCTTGGGTG CCTTTCCATT TTCTGTTTTC ATTTTGATGG 360
TGATCTAAAT GAGAAATAAA AAGAAGCCTG TTCTTGTTCA CCTGGTTGAC TGCTGGCTGG 420
GGGCTGCCCC TGGAGATGAG GAAGCAGGAA CATGGGGTTT GATCGCTCCT GTGTGGCAAA 480
GTGTTTGCTG AATTTGCACT GGGCCACTGC TGCAGGTTGT GATGGAGGTC GAGGGTGAGC 540
AGGGCTTAGC AGCTGGCAGC TCCAGGATCC CATGGACTTG GAAATGTATC CCTCCTCGGC 600
CACTTCCCAT GAGTCTAGCC CTGGGTAAAG GTCTTTTCCT CTCTGAGTCA CAGTGTTCTC 660
TACTGAATGG AACCACTTTT CCTTCTTTGT CAAGGATTAA ATAGGTCATT TAATGACTTA 720
GCCTGTGGTT GGGATTCGGT AGGTGGGCAC ATTGTTCCTA CTTCTCTCTG AGTGGCGGCA 780
ACATTTGAAG CTGGCAGATT CTTCTGGGCC CTGGCGGAGG TGCTGTACTC TCCACTGGAT 840
TCAAAGGGAG AAGGTAAGAA GGAGACTGGT AGCATTGATT GCTCTGCCTG CCTGTCTCTG 900
CAGAGTCTCC ATAGACTGTA GAGCTGGAAG GGCATGATCT CATGCAGAAA CCAGTGGCCA 960
GACAAGGGAA GTGACTGTCC CTGTCACATG GCTAGCAAGC AGGCCAGGCA GGATGAGAGC 1020
TCAGGCCTTG TGACTTCCCG TTCAGTGCTC TCCACTGTTC CTCTCAGTTG ATAAGTGGTC 1080
CTGAGACCAC CTGTGCTCCT TGCAGCCTAG TAAACCCCCT TCTCTCTTAT TTATTTATTT 1140
TTGAGACACT CTCACTCTGT TGCCCAGGCT GGAGTGCATT GGTGCAATCT TGGCTCACTG 1200
TAACCTCCGT CTCCCAGGTT CAAGCGATTC TCCTGCCTCA GCCTTCTGAG TAGCTGGGAC 1260
TACAGGCGCC CGTCACCACA 1280
|
| |
|
|
|
